Test Directory
| Test Code | |||||
| TEAB | |||||
| Test Name | |||||
| Tetanus Antitoxoid Antibodies | |||||
| CPT Codes | |||||
| 86317 | |||||
| Expected Turnaround Time | |||||
| 1 - 5 days | |||||
| Clinical Utility | |||||
|
This test is used to assess immunity against tetanus by determining levels of circulating antibodies to tetanus toxin or to measure the immune response, postvaccination, in individuals suspected of immunodeficiency disorders. |
|||||
| Specimen and Container Info | |||||
|
Specimen Type: Serum Collection Container: Gold Top, Serum Separator Alternate Collection Container: Red Top, Plain Specimen Volume: 1 mL |
|||||
| Collection Instructions | |||||
|
|||||
| Processing and Submission Instructions | |||||
|
|||||
| Transport Instructions | |||||
|
Transport to the laboratory refrigerated. |
|||||
| Stability Requirements | |||||
|
|||||
| Causes for Rejection | |||||
|
|||||
| Methodology | |||||
| Enzyme Immunoassay | |||||
| Reference Intervals | |||||
|
See patient report. |
|||||
| Limitations | |||||
|
Determination of tetanus toxoid antibodies is of no value in assessing the need for prophylactic or therapeutic management. Immunity declines with age, and boosters are recommended every 10 years. This procedure may be considered by Medicare and other carriers as investigational and, therefore, may not be payable as a covered benefit for patients. |
|||||
| Reference Lab | |||||
| Labcorp Of America Holdings | |||||
| Testing Schedule | |||||
| Routine, 3 times per week | |||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.